Ulcerative Colitis Clinical Trials in Phoenix

Showing 21-40 of 317 trials

Double-J PLUS Postmarket Registry Study

NCT04197583

A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents

Ureter Obstruction

Boston Scientific Corporation379 participantsStarted Feb 2020

Phoenix, Arizona, United States • Chicago, Illinois, United States • Glenview, Illinois, United States +7 more locations

RECRUITINGPHASE3< 1 mile

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.

Chronic Obstructive Pulmonary Disease

Hoffmann-La Roche2,000 participantsStarted Jun 2023

Birmingham, Alabama, United States • Dothan, Alabama, United States • Jasper, Alabama, United States +479 more locations

Double-J PLUS Postmarket Registry Study

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Ulcerative Colitis Trials in Other Cities

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation

Clinical Validation of the RENISCHEM L-FABP POC Assay

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Microdystrophin Gene Transfer Study in Adolescents and Children With DMD

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

Other Conditions in Phoenix